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http://www.biomedcentral.com/1746-6148/10/78RESEARCH ARTICLE Open AccessTick-borne encephalitis virus (TBEV) – findings on
cross reactivity and longevity of TBEV antibodies
in animal sera
Christine Klaus1*†, Ute Ziegler2†, Donata Kalthoff3†, Bernd Hoffmann3† and Martin Beer3†Abstract
Background: By using animal sera as sentinels, natural TBEV foci could be identified and further analyses including
investigations of ticks could be initiated. However, antibody response against TBEV-related flaviviruses might
adversely affect the readout of such a monitoring. Therefore, the cross-reactivity of the applied TBEV serology test
systems – enzyme linked immunosorbent assay (ELISA) and virus neutralization test (VNT) – as well as the longevity
of TBEV antibody titres in sheep and goats were investigated in this study.
Results: Cross-reactivity of the TBEV antibody test systems with defined antibody-positive samples against selected
members of the Flaviviridae family (e.g. Louping ill virus, West Nile virus) was observed for Louping-ill-positive sera
only. In contrast, the commercial West Nile virus (WNV) competitive ELISA showed a high level of cross-reactivity
with TBEV-specific positive sera.
To assess the longevity of TBEV antibody titres, sera from two sheep and two goats, which had been immunized
four times with a commercially available TBEV vaccine, were tested routinely over 28 months. In three of the four
animals, TBEV-specific antibody titres could be detected over the whole test period.
In addition, sera from the years 2010 and 2011 were collected in flocks in different villages of Baden-Württemberg
and Thuringia to allow re-examination two to four years after the initial analysis. Interestingly, in most cases the
results of the former investigations were confirmed, which may be caused by steadily existing natural TBEV foci.
Conclusion: Cross-reactivity must be taken into consideration, particularly for TBEV serology in regions with a prevalence
of Louping ill virus and for serological testing of WNV by cross-reactive ELISAs. Furthermore, over-interpretation of single
TBEV-positive serological results should be avoided, especially in areas without a TBEV history.
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Tick-borne encephalitis (TBE) is the most important viral
tick-borne zoonosis in Europe [1]. TBE virus (TBEV) circu-
lates between ticks and hosts in geographically strictly lim-
ited natural foci, which can range in size from large to very
small. However, the reason for the patchwork-like spread
of TBEV is unclear [2-4]. TBEV prevalence in ticks in these
natural foci is very low [5-7], and detection of a natural
TBEV focus by collecting and testing ticks is very expensive* Correspondence: DrChristineKlaus@gmail.com
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unless otherwise stated.and time-consuming [8]. Against this background, assess-
ment of the TBEV sero-prevalence in free-ranging animals
provides a suitable and valuable additional source of infor-
mation about TBEV foci in their smaller or larger patchy
pattern [9-11].
In general, knowledge on TBE in animals is limited;
however infections have been reported in dogs [12-15],
monkeys [16,17], and horses [4,18]. Furthermore serocon-
version without specific clinical signs of TBE has been de-
scribed in some animal species such as cattle and small
ruminants [11,19,20]. Clinical cases of TBE in ruminants
are very seldom; one case of a mouflon (Ovis ammon musi-
mon) for example has been reported from Austria [21].
However, these animals are of significant public health
relevance. Especially goats and sheep, more rarely cattle,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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During viraemia, the virus is excreted in milk and can
be ingested orally by consumption of non-pasteurized
milk or cheese produced from raw milk [22-25]. TBE in
humans caused by virus-infected milk has occurred in
many countries, in the last ten years in Hungary, Austria
and Estonia [26-28].
These grazing animals have been shown to be suitable
sentinels for the detection of antibodies against TBEV
[11], but some questionable points require further exam-
ination: (i) the possibility of cross-reactivity of the tested
sera with related flaviviruses and (ii) the longevity of
TBEV antibody titres in grazing animals.
One example of known cross-reactivity between mem-
bers of the flavivirus genus comes from serological West
Nile virus (WNV) diagnostics [29]. WNV is considered
to be the most widespread flavivirus in the world and is
transmitted and maintained in an enzootic mosquito-
bird cycle [30,31]. Horses can be infected by bridge vec-
tors and develop subclinical infection or neurological
disease. False WNV positive ELISA results from horses
have been attributed to cross-reactivity with TBEV spe-
cific antibodies and complicate monitoring studies on
the WNV sero-prevalence [32].
Here we present results on cross-reactivity within the
TBEV-specific serology, but also provide a strategy to
identify TBEV antibodies as the cause of false positive
reactions in serological tests for other flaviviruses using
WNV as an example.Methods
Collection of samples
Sera positive for Flavivirus specific antibodies
To determine cross-reactivity, five Louping ill virus (LIV)
antibody-positive reference sera from sheep (kindly pro-
vided by Kim Willoughby, Moredun-Institute, UK) as well
as WNV-positive sera from the National Reference La-
boratory for WNV (Friedrich-Loeffler-Institut, Greifswald-
Insel Riems, Germany) were tested. The WNV sample
panel included 15 equine sera (field sera or sera collected
after vaccination), and 10 hyperimmune-sera from vac-
cinated ducks, chickens and rabbits. Additionally, two
rabbit sera with antibodies against Usutu virus (USUV)
and Japanese encephalitis virus (JEV), respectively, were
analyzed.
Furthermore, ascites liquid from mice immunized against
TBEV-related viruses such as Russian-spring-summer-
encephalitis virus (RSSEV), Powassan virus (POWV),
Yellow fever virus (YFV), JEV and St. Louis encephalitis
virus (SLEV) could be investigated (kindly provided by
Gerhard Dobler, Bundeswehr Institute of Microbiology,
Munich, Germany). Each sample was diluted 1:10, 1:50,
1:100, 1:500, and 1:1000 before testing (Table 1).Field sera from horses were collected in two different
herds in Bavaria, and sera from TBEV-positive horses [4]
were also included (Table 2).
Sera collected to analyze the longevity of the humoral
immune response
Two goats and two sheep were immunized four times as
described by Klaus et al. [33] and TBEV antibody titres
were traced over a period of 28 months (Table 3).
In addition, different field sera were included in the
analysis: sera from sheep and goat flocks from the TBE
risk areas “Ortenaukreis”, “Bodenseekreis” and “Breisgau-
Hochschwarzwald (HS)”, and sera from the TBE non-risk
area “Altenburger Land” which were collected in 2010
and 2011 (Table 4). Although the sera did not come from
the same individual animals, the datasets were compared
to the sero-prevalence results exhibited by the same flocks
in 2006 and 2009 [11].
In addition, in Salem, district Bodenseekreis, not only
sera but also ticks were collected in 2011 (89 female,
116 male, 1537 nymphs, 46 larvae) in the vicinity of the
monkey mountain, where in 2006 TBEV strain Salem
had first been isolated from a monkey (Macaca sylvanus)
[16,17] and sheep sera had been collected and examined
in 2008/2009 [34], but TBEV-RNA in ticks has not been
detected so far. Ticks were pooled (up to 5 female, 5 male,
10 nymphs, 20 larvae), examined for TBEV-RNA and
positive pools were sequenced as described [4].
Test systems
TBEV specific serology
All sera were examined by means of a two-step method
[33,34], which consisted of (I) first screening with a modi-
fied TBEV-antibody ELISA (Immunozym FSME IgM kit,
Progen GmbH, Heidelberg, Germany) allowing analysis of
the whole immunoglobulin fraction and (II) subsequent
confirmation of all ELISA-positive or questionable results
by a virus neutralization test (VNT; [10]). Only sera con-
firmed by VNT were finally classified as TBEV antibody
positive.
WNV specific serology
For detection of WNV-specific antibodies, horse samples
were investigated by a commercially available competition
ELISA, which allows the species-independent recognition
of WNV antibodies against the PrM- and E envelope pro-
tein (ID Screen® West Nile Competition, IDVet, Grabels,
France). Additionally, all serum samples were tested for
neutralizing WNV antibodies by VNT with the WNV
strain NY 99 (lineage 1, accession no. AF196835) and/or
strain Austria (lineage 2, accession no. HM015884, kindly
provided by Dr. N. Nowotny, Institute of Virology, Uni-
versity of Veterinary Medicine, Vienna) as described previ-
ously [35].
Table 1 Cross-reactivities of TBEV-ELISA and TBEV-VNT results
Sample number Animal Antibodies classified as (ND50) TBEV-ELISA TBEV-VNT (ND50)
Serum 1 Sheep Louping ill-positive Positive Positive (1:20)
Serum 2 Sheep Louping ill-positive Negative Negative (1:5)
Serum 3 Sheep Louping ill-positive Positive Positive (>1:40)
Serum 4 Sheep Louping ill-positive Positive Positive (>1:40)
Serum 5 Sheep Louping ill-positive Positive Positive (>1:40)
Serum 6 Horse WNV positive (1:320) Negative Negative (<1:10)
Serum 7 Horse WNV positive (1:480) Negative Negative (<1:10)
Serum 8 Horse WNV positive (1:1280) Borderline Positive (1:40)
Serum 9 Horse WNV positive (1:160) Negative Negative (<1:10)
Serum 10 Horse WNV positive (1:240) Negative Negative (<1:10)
Serum 11 Horse WNV positive (1:60) Borderline Positive (1:80)
Serum 12 Horse WNV positive (1:40) Negative Negative (<1:10)
Serum 13 Horse WNV positive (1:80) Negative Negative (<1:10)
Serum 14 Horse WNV positive (1:35) Negative Negative (<1:10)
Serum 15 Horse WNV positive (1:120) Negative Negative (<1:10)
Serum 16 Horse WNV positive (1:60) Negative Negative (<1:10)
Serum 17 Horse WNV positive (1:80) Negative Negative (<1:10)
Serum 18 Horse WNV positive (1:240) Negative Negative (<1:10)
Serum 19 Horse WNV positive (1:20) Negative Negative (<1:10)
Serum 20 Horse WNV positive (1:40) Negative Negative (<1:10)
Serum 21 Horse WNV positive (1:60) Negative Negative (<1:10)
Serum 22 Horse WNV positive (1:1280) Negative Negative (<1:10)
Serum 23 Chicken WNV positive (1:500) Negative Negative (<1:10)
Serum 24 Chicken WNV positive (1:250) Negative Negative (<1:10)
Serum 25 Chicken WNV positive (1:80) Negative Negative (<1:10)
Serum 26 Chicken WNV positive (1:900) Negative Negative (<1:10)
Serum 27 Duck WNV positive (1:80) Negative Negative (<1:10)
Serum 28 Duck WNV positive (1:60) Negative Negative (<1:10)
Serum 29 Rabbit WNV positive (1:120) Negative Negative (<1:10)
Serum 30 Rabbit WNV positive (1:480) Negative Negative (<1:10)
Serum 31 Rabbit WNV positive (1:80) Negative Negative (<1:10)
Serum 32 Rabbit WNV positive (1:60) Negative Negative (<1:10)
Serum 33 Rabbit JEV positive (1:60) Negative Negative (<1:10)
Serum 34 Rabbit JEV positive (1:80) Negative Negative (<1:10)
Serum 35 Rabbit USUV positive (1:1280) Negative Negative (<1:10)
Serum 36 Rabbit USUV positive (1:80) Negative Negative (<1:10)
Ascites 1 Mouse RSSEV-positive Positive* Positive (1:75)
Ascites 2 Mouse POWV-positive Negative* Negative (<1:25)
Ascites 3 Mouse YFV-positive Negative* Negative (<1:25)
Ascites 4 Mouse JEV positive Negative* Negative (<1:25)
Ascites 5 Mouse SLEV positive Negative* Negative (<1:25)
*all samples diluted 1:10, 1:50, 1:100, 1:500, 1:1000, only results 1:10 are shown in the table, all samples diluted between 1:50 and 1:1000 were negative.
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Table 2 Cross-reactivity of horse sera between ELISA and VNT
TBEV-ELISA TBEV-VNT WNV-ELISA WNV-VNT
Sample U/l 1 Result ND50 S/N% Result ND50
Serum 1 −2,995 Negative n.d. 92,25% Negative < 1:10
Serum 2 12,500 Borderline >1:640/1:960 11,99% Positive < 1:10
Serum 3 −2,938 Negative n.d. 88,04% Negative < 1:10
Serum 4 −3,802 Negative n.d. 94,11% Negative < 1:10
Serum 5 3,859 Negative n.d. 41,48% Borderline < 1:10
Serum 6 17,627 Positive 1:80 7,27% Positive < 1:10
Serum 7 −2,650 Negative n.d. 77,31% Negative < 1:10
Serum 8 −3,571 Negative n.d. 86,93% Negative < 1:10
Serum 9 −3,168 Negative n.d. 90,48% Negative < 1:10
Serum 10 3,111 Negative n.d. 3,16% Negative < 1:10
Serum 11 −0,806 Negative n.d. 93,43% Negative < 1:10
Serum 12 −3,975 Negative n.d. 93,54% Negative < 1:10
Serum 13 −2,995 Negative n.d. 92,59% Negative < 1:10
Serum 14 −3,744 Negative n.d. 89,52% Negative < 1:10
Serum 15 −2,995 Negative n.d. 88,38% Negative < 1:10
Serum 16 4,896 Negative n.d. 86,58% Negative < 1:10
Serum 17 −3,168 Negative n.d. 85,80% Negative < 1:10
Serum 18 −2,765 Negative n.d. 91,29% Negative < 1:10
Serum 19 17,915 Positive 1:80 15,04% Positive < 1:10
Serum 20 20,392 Positive 1:240 51,14% Negative < 1:10
Serum 21 12,212 Borderline 1:160 13,51% Positive < 1:10
Serum 22 17,569 Positive 1:320 9,48% Positive < 1:10
Serum 23 −3,053 Negative n.d. 84,21% Negative < 1:10
Serum 24 −3,399 Negative n.d. 83,57% Negative < 1:10
Serum 25 16,993 Positive 1:80 7,06% Positive < 1:10
Serum 26 −4,818 Negative n.d. 89,77% Negative < 1:10
Serum 27 −5,867 Negative n.d. 83,66% Negative < 1:10
Serum 28 −3,959 Negative n.d. 84,43% Negative < 1:10
Serum 29 −5,295 Negative n.d. 91,08% Negative < 1:10
Serum 30 10,351 Borderline <1:5 86,85% Negative < 1:10
Serum 31 −5,200 Negative n.d. 86,23% Negative < 1:10
Serum 32 −4,532 Negative n.d. 86,37% Negative < 1:10
Serum 33 31,245 Positive >1:40/1:720 27,45% Positive < 1:10
Serum 34 14,168 Positive >1:40/1:480 76,10% Negative < 1:10
Serum 35 21,991 Positive 1:40 40,69% Borderline < 1:10
Serum 36 35,443 Positive >1:40/>1:960 21,43% Positive < 1:10
Serum 37 −5,581 Negative n.d. 86,84% Negative < 1:10
Serum 38 −4,913 Negative <1:5 88,36% Negative < 1:10
Serum 39 35,538 Positive >1:40/1:480 6,68% Positive < 1:10
Serum 40 30,291 Positive >1:40/1:960 17,62% Positive < 1:10
Serum 41 −5,200 Negative <1:5 85,33% Negative < 1:10
Serum 42 −3,864 Negative n.d. 86,76% Negative < 1:10
Serum 43 −5,486 Negative n.d. 87,18% Negative < 1:10
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Table 2 Cross-reactivity of horse sera between ELISA and VNT (Continued)
Serum 44 −3,959 Negative n.d. 87,91% Negative < 1:10
Serum 45 −5,200 Negative n.d. 86,37% Negative < 1:10
Serum 46 13,691 Positive >1:40/>1:960 3,07% Positive < 1:10
In bold = TBEV-positive horses would result in false positive outcomes in the commercial WNV-ELISA, but clearly negative in the WNV-specific VNT.
n.d. = not done.
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Cross-reactivity in TBEV-serology
The majority of samples from the tested Flavivirus-
antibody-positive-panel (Table 1) showed clearly negative
results using the TBEV-ELISA. Sera with specific antibodies
to non-TBEV flaviviruses, such as WNV, JEV, USUV, YFV,
SLEV or POWV, scored also clearly negative using the
TBEV-ELISA. Nevertheless, four out of five LIV-antibody-
positive sheep sera reacted positive in the TBEV-ELISA
as well as in the TBEV-VNT. In addition, RSSEV reactive
mouse ascites scored also positive in both, the TBEV-
ELISA and the TBEV-VNT, but only at the lowest dilution
of 1:10 (Table 1).
Cross-reactivity in WNV serology
The fifteen WNV-positive horse sera were classified as
clearly negative in the TBEV-ELISA, which was confirmed
by the TBEV-VNT. Furthermore, 10 WNV-specific hyper-
immune sera from vaccinated chickens, ducks and rabbits
were clearly negative both in the TBEV-ELISA and the
TBEV-VNT. The same could be shown for the two hyper-
immune sera from JEV and USUV vaccinated rabbits, re-
spectively (Table 1). Therefore, WNV-specific antibodies
did not obviously cross- react with our TBEV-specific ser-
ology testing.
In contrast, WNV-negative (verified by WNV-specific
VNT) horse sera scored positive in the commercial
WNV-ELISA. Here it could be verified that TBEV-specific
antibodies (ELISA and VNT) were the source of cross-
reactivity. These results therefore indicate that TBEV-
specific antibodies did interfere with WNV-specific ELISA
diagnostics and have to be taken into account (Table 2).Table 3 Longevity of TBEV-antibody titres (VNT) in two
immunized goats and sheep
Month* Goat 1** Goat 2** Sheep 1** Sheep 2**
0 <1:5 <1:5 <1:5 <1:5
6 1:60 1:80 1:80 1:80
12 1:80 1:120 1:80 1:80
18 1:60 1:320 1:10 1:20
24 1:30 1:120 1:30 1:20
28 1:80 1:80 1:30 1:60
*sera examined every month, only selected data shown.
**immunized in week 0, 1, 3 and 11 with one dose of FSME-IMMUN Erwachsene
(Baxter Deutschland GmbH, Germany), as described in [33].
<1:5 = negative.Longevity of TBEV-specific antibody titres in immunized
animals and re-testing of sentinel flocks for
long-term observations
The development of TBEV-specific antibody titres over a
time span of more than two years is shown in Table 3.
TBEV-specific antibody titres increased in the vaccinated
sheep and goats until 18 weeks after the first immunization
and started to decrease to lower VNT titres over the
following weeks to reach lower but still positive titres
28 months after vaccination (Table 3).
In order to track the development of TBEV-antibodies in
the field situation, selected flocks in Baden-Wuerttemberg
and Thuringia (Table 4) were repeatedly tested within a
time interval of one to four years. Interestingly, the ini-
tial results reported for the districts “Bodenseekreis”,
“Breisgau-HS”, and “Ortenaukreis” (Baden-Wuerttemberg),
were confirmed [11]. For example, in the sheep flock in
Salem (district “Bodenseekreis”) a TBEV-sero-prevalence
of 13% was detected (in 2008/2009: 9%), in the goat flock
in “Sulzburg” (district “Breisgau-HS”) 17.8% were seen
(2006–09: 43%), and in a goat flock in “Nordrach” (district
“Ortenaukreis”) 42.8% scored positive (2008: 60%). These
findings are in good agreement with the TBE-risk-area sta-
tus as determined by the Robert Koch-Institute [36,37].
All animal experiments in this study were conducted
in strict accordance with a high standard of veterinary
care. The protocols were approved by the competent
authority of the Federal State of Thuringia, Thuringian
State Office for Food Safety and Consumer Protection,
Dept. of Health Protection, Veterinary Medicine and
Pharmacy, Bad Langensalza, Thuringia, Germany (Reg.
no. 04-104/10) and reviewed and approved by the com-
petent authority of the Federal State of Mecklenburg-
Western Pomerania, State Office for Agriculture, Food
Safety and Fisheries, Rostock, Mecklenburg-Western
Pomerania, Germany (LALLF M-V/TSD/7221.3-2.5.1-
002/11).
In addition to these serological results in Salem
(Bodenseekreis) 1788 collected ticks in 208 pools were
analyzed by TBEV-specific RT-qPCR and in one pool of 10
nymphs collected around the monkey mountain TBEV-
RNA was detected. The nucleotide sequence (2866 nt in
total) of the structure protein genes of TBEV were de-
termined (GenBank KC292217) and compared with the
TBEV sequences available in the NCBI GenBank data-
base using BLAST. The highest homology with 99.55%
Table 4 Re-tested goat flocks for TBEV-specific antibodies (Thuringia-TH, Baden-Wuerttemberg-BW) and sheep flocks
(Baden-Wuerttemberg-BW), re-collected in 2010/11
Country District Flock (village) Year Species No. of sera No. of positive sera Seroprev. (%)
BW Bodenseekreis S1 (Salem) 2011 sheep 100 13 13
BW Bodenseekreis S1 (Salem) 2008-09* sheep 100 9 9
BW Breisgau (HS) Sulzburg 2010 goats 28 5 17,8
BW Breisgau (HS) Sulzburg 2006-09* goats 28 12 43
BW Breisgau (HS) different flocks** 2010 goats 355 4 1,1
BW Breisgau (HS) different flocks** 2006-09* goats 349 13 3,7
BW Ortenaukreis Nordrach 2010 goats 28 12 42,8
BW Ortenaukreis Nordrach 2008* goats 20 12 60
BW Ortenaukreis various flocks*** 2010 goats 100 15 15
BW Ortenaukreis various flocks 2008* goats 355 51 14,4
TH Altenburger Land A1 (Altkirchen) 2011 goats 90 0 0
TH Altenburger Land A1 (Altkirchen) 2009* goats 73 5 7
*in detail published in [11].
**re-tested flocks from Horben, Münstertal and Löffingen-Dittishausen, results not shown in detail.
***flocks from Haslach, Kürzell-Meißenheim, Offenburg, Hohberg, results not shown in detail.
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72210). Here 2853 nt of the compared 2866 nt were
identical.
Interestingly, the results from a flock in Thuringia sur-
veyed in 2009 could not be confirmed: In 2009, surpris-
ingly five out of 73 sera in this goat flock in “Altkirchen” in
the district “Altenburger Land”, Thuringia, which is defined
as a TBE non-risk area, tested TBEV-antibody-positiveFigure 1 Places of re-tested flocks in Baden-Wuerttemberg and Thuri
4: Altenburger Land; star: in addition tick collection site.[11]. In 2011, we tested 90 sera from this flock and did not
find any TBEV-antibody-positive sera (Table 4). The map
(Figure 1) shows the four districts where sera were
collected.
Discussion
A limited cross-reactivity of non-TBEV, but flavivirus-
antibody-positive sera was observed in the TBEV-specificngia. 1: Bodenseekreis; 2: Breisgau-Hochschwarzwald; 3: Ortenaukreis;
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regions with a risk for TBEV infection. Four of five sera
defined as LIV-antibody positive and ascites from a RSSEV-
infected mouse reacted positive in the ELISA as well as
in the VNT assay (Table 1). Therefore, TBEV-serology in
most cases is not able to differentiate between LIV-
antibody-positive, RSSEV-antibody-positive and TBEV-
antibody-positive sera, and an intense cross-reactivity of
sera specific for these related viruses must be assumed.
Phylogenetic analysis of the genus Flavivirus confirmed
the close relationship of LIV, RSSEV and TBEV [38].
However, since to our knowledge human TBE cases have
not been described in Great Britain [1,39], it must be con-
cluded that double infection with Louping ill and TBEV as
a reason for these results can be excluded. Cross-reactivity
would only be relevant in countries where both diseases
are present. In Germany, Louping ill as well as RSSE has
not been observed to date [39]. In addition, clinical signs
of Louping ill in sheep are severe, while TBE infection in
ruminants normally is subclinical [39-41].
Furthermore, no cross-reactivity was observed between
our TBEV test system (ELISA and VNT) and defined
WNV-positive horse sera (Table 1).
It is well-known, that the used commercial competitive
WNV-ELISA cross-reacts with other flaviviruses [29,32],
necessitating the use of virus-specific neutralization as-
says for the final determination of the etiologic flavivirus.
Here, the cumulative occurrence of false-positive WNV-
results with the used commercial WNV-ELISA system
(Table 2) is the consequence of a clear cross-reactivity
with TBEV-specific antibodies. In this case, a reasonable
discrimination is only possible by means of a virus-specific
neutralization assay. The results of this study are there-
fore in good agreement with those of a previous study
[29]. In Germany, TBEV-related diseases in horses have
been reported recently [4,42]. Müller et al. [42] investi-
gated a population of 240 horses in the endemic region
of Marburg-Biedenkopf and identified 2.9% horses with
TBEV-neutralizing antibodies. Consequently, TBEV should
be considered as an important and relevant differential
diagnosis for WNV infections in horses, although there is
no evidence for indigenous WNV infections in Germany
so far [32]. Our results are in accordance with a similar
study in Austria, where an unexpectedly high serocon-
version rate against TBEV was identified in a large herd
of horses [43]. Therefore, our TBEV test system could
also be helpful for clarifying non-specific serological
WNV antibody-reactive results in regions without a
WNV history.
On the other hand, testing of horses can even be used
as an indicator to detect TBEV-affected areas and thus
identify a TBEV focus.
In summary, our TBEV antibody test system is well
suited and, despite a partial cross-reactivity to LIV- andRSSEV-antibodies, cross-reactivity with other flaviviruses
is not to be expected in countries like Germany. How-
ever, the number of samples tested so far has been low,
so these findings should be verified in future studies.
In our investigations on the longevity of TBEV anti-
body titres, only small differences were seen between the
two immunized goats and sheep. TBEV-specific antibody
titres were still detectable after 28 months with lower but
specific titres in the two goats and two sheep (Table 3).
While the progress of TBEV antibody titres reflects the
situation after immunization with an inactivated vaccine,
natural infection might result in relatively similar humoral
immune responses; e.g. in horses it was possible to re-test
naturally infected TBEV-antibody-positive animals. In two
flocks in Bavaria, all six TBEV antibody-positive horses
which were re-tested after nine months had VNT-positive
titres and it was also possible to detect TBEV in ticks col-
lected in the vicinity of the stables [4]. Also Leschnik et al.
[14] observed TBEV titres in dog sera for nine months
after natural infection.
In addition, in repeatedly tested goat and sheep flocks
the detected sero-prevalences were in good accordance
with the epidemiological TBEV situation in the surround-
ings. In the district “Bodenseekreis”, a defined TBE risk
area with a very long TBEV history, 60 human cases were
registered between 2001 and 2012, and the existence of a
TBEV natural focus in Salem described in animals in 2006
[16,17,34] was re-confirmed by TBEV antibody-positive
sheep sera (Table 4). Detection of TBEV-RNA (GenBank
KC292217) closely related to the TBEV strain “Salem“
(GenBank FJ572210) in one pool of 10 nymphs among
1788 collected ticks also confirmed the serological results
(data not shown in detail). This strain was first isolated
and sequenced from a monkey (Macaca sylvanus) from
the monkey mountain Salem with severe neurological clin-
ical symptoms in 2006 [16,17]. However, until our here
presented results TBEV-RNA could not be found in ticks
at this place. . After our investigations in horse herds in
Bavaria [4] it was an additional case where sera from graz-
ing animals as sentinels were successfully used for a tar-
geted tick collection to detect TBEV-RNA.
The districts “Breisgau-HS” and “Ortenaukreis” also have
a well-known TBEV history with 64 (Breisgau-HS) and 246
(Ortenaukreis) human cases, respectively, between 2001
and 2012.
In the goat flock in “Altkirchen”, district “Altenburger
Land” (Thuringia), however, re-testing provided a differ-
ent unexpected result. Surprisingly, in 2009, five of 73
sera from this TBE non-risk area with so far no human
TBE cases had been found to be TBEV antibody-positive
(7%). In 2011, 90 sera from new goats of this flock were
re-tested and no TBEV antibody-positive results were
detected (Table 4). One reasonable explanation might be
the elimination of the relevant animals from the flock,
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sible for more than 28 months.
Therefore, detection of a small number of TBEV
antibody-positive sera in TBEV non-risk areas with no
human TBE cases should be interpreted with care (ani-
mals might originate from TBE risk areas). However, the
longevity data support the conclusion that sera from
grazing animals are well suited as a valuable source of
serological data supporting the TBEV status of an area.Conclusions
TBEV-specific sero-prevalences in animals are an add-
itional valuable tool that can help identify natural TBEV
foci which are in most cases spread in a patchwork-like
pattern. Cross-reactivity is rare and does not play a sig-
nificant role in countries without a prevalence of a broad
range of TBEV-related flaviviruses. Furthermore, TBEV
is a very important and relevant cause for false-positive
WNV-ELISA results in horses and must be taken into
consideration in monitoring or sentinel programs.
Finally, all TBEV serology results should be interpreted
in close cooperation between human and veterinary medi-
cine, and recommendations for the vaccination of humans,
based exclusively on the TBEV sero-prevalence in animals
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